Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer.
Iveson T., Kerr R., Saunders MP., Hollander NH., Tabernero J., Haydon AM., Glimelius B., Harkin A., Scudder C., Boyd K., Waterston AM., Medley LC., Wilson C., Ellis R., Essapen S., Dhadda AS., Harrison M., Falk S., Raouf S., Paul J.